“Bonjela Bites the Dust: Teething Gel to be Removed from Aussie Supermarkets”

Bonjela Teething Gel and Bonjela Mouth Ulcer Gel to be Removed from Supermarket Shelves

Starting from October 1, Bonjela Teething Gel and Bonjela Mouth Ulcer Gel, commonly used to relieve the pain, discomfort, and irritability associated with teething and mouth ulcers, will no longer be available on supermarket shelves in Australia. The Therapeutic Goods Administration (TGA) has reclassified these products from Schedule 1 to Schedule 2 medicines due to concerns about toxicity levels resulting from misuse. This change means that these gels will only be available for purchase at pharmacies in Australia.

Concerns Over Misuse and Toxicity Levels

The decision by the TGA to reclassify Bonjela products was prompted by concerns about the potential for toxicity when the active ingredient, choline salicylate, is overdosed. Choline salicylate is a non-steroidal anti-inflammatory (NSAID) that can lead to toxicity when the products are not used as directed. Overdosing can happen when too much gel is used, when it is used too frequently, or when it is used over an extended period of time.

According to pharmacist Alyssa Fusillo, the risk of overdose toxicity is greater in children. Fusillo stated that although choline salicylate is safe when used at the recommended dose, it is important for consumers to have access to professional advice to ensure proper usage.

Reclassification to Ensure Professional Advice and Safer Use

By reclassifying Bonjela products as Schedule 2 medicines, the TGA aims to ensure that parents have access to professional advice each time they purchase these gels. This means that a pharmacist’s consultation will be required for safe use. The reclassification is intended to address concerns about the risks associated with misuse and overuse of the products.

Fusillo emphasized the importance of using the medication at the right time, frequency, and duration. For example, Choline Salicylate should not be used for more than three days, given more than six times in three hours, or used for longer than three hours. If parents find themselves relying on the product beyond the recommended timeframe, they should seek further advice from their pharmacist.

Alternatives and Guidelines

For parents looking for alternatives to Bonjela products, Fusillo recommended chilled teething rusks, oral analgesics like paracetamol and ibuprofen, and offering other cool things like yogurt to soothe teething pains. It is worth noting that the therapeutic guidelines in Australia do not recommend teething gels, regardless of choline salicylate content, due to a lack of evidence of efficacy and the potential for harm.

Supermarkets Ceasing Sales, Availability at Pharmacies

As a result of the reclassification, Woolworths has already ceased orders for Bonjela products, and remaining stock is expected to be sold out by the end of September. Coles will also stop selling Bonjela and is currently running down its stock. Starting October 1, 2023, products containing choline salicylate for oromucosal use (administered via the mucus systems in the mouth) will be classified as pharmacy medicines (Schedule 2).

The TGA’s schedules range from 1 to 10, with Schedule 4 medicines requiring a prescription and Schedule 10 medicines being substances of such danger to health that their sale, supply, and use are prohibited.

Editorial: Prioritizing Safety and Professional Advice

The reclassification of Bonjela products from Schedule 1 to Schedule 2 medicines reflects the TGA’s commitment to ensuring the safe use of these gels and protecting consumers, particularly children, from the potential risks of toxicity associated with misuse. By requiring a pharmacist’s consultation for purchase, parents will have access to professional advice that can help them navigate the appropriate usage of these products.

While the removal of Bonjela products from supermarket shelves may cause inconvenience to some consumers, it is essential to prioritize safety and educate users about proper usage. The availability of alternative options and advice from pharmacists can help parents find suitable alternatives for relieving teething pains and mouth ulcers.

Australian parents should be proactive in seeking guidance from healthcare professionals, including pharmacists, to ensure they are well-informed about the best and safest methods to soothe their children’s discomfort. Additionally, adhering to recommended dosage and usage guidelines is crucial to prevent potential harm.

Conclusion: Seeking Professional Advice for Safer Medication Use

The reclassification of Bonjela Teething Gel and Bonjela Mouth Ulcer Gel to Schedule 2 medicines underscores the importance of seeking professional advice and following usage guidelines for safe medication use. Parents should consult pharmacists for guidance on alternative options and proper dosing for teething and mouth ulcer relief. Prioritizing safety and informed decision-making will ensure the well-being of children and promote responsible medication usage.